PHRINL Syndrome: A Case of Infantile Cataract and Cardiomyopathy
Molecular Syndromology · 02.04.2026 · 1-7
DOI: 10.1159/000551787 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Syndromology, online erschienen am 02.04.2026. Verfasst von Aliye Gülbahçe und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Nutrition and Metabolism, Kocaeli City Hospital, Kocaeli, Türkiye. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
Pontocerebellar Hypoplasia, Hypotonia, and Respiratory Insufficiency Syndrome, Neonatal Lethal (PHRINL Syndrome) is a rare genetic disorder caused by impaired oxidative phosphorylation due to reduced activity of mitochondrial complexes I, IV, and V. The condition results from homozygous or compound heterozygous pathogenic variants in the ATAD3A gene, and is inherited in an autosomal recessive manner. Affected individuals typically present in early infancy with hypotonia, encephalopathy, corneal clouding, cardiomyopathy, and respiratory failure, and often die during infancy. Case Presentation: A 40-day-old female infant was referred for evaluation of a possible inherited metabolic disorder following the death of her brother at 9 months of age. No abnormalities were detected in the metabolic workup. Hypotonia was identified on physical examination at 3 months of age, brain magnetic resonance imaging (MRI) revealed pontocerebellar hypoplasia. Whole-exome sequencing (WES) identified two genetic alterations in the ATAD3A gene, leading to the diagnosis of PHRINL Syndrome. ATAD3A (NM_001170535.3: c.229C>G; p.Leu77Val) c.229C>G heterozygous missense variant was detected, along with a 0.61 kb heterozygous deletion encompassing exons 3–4 of the ATAD3A gene. The patient diagnosed with hypotonia at 3 months of age, developed cataracts at 5 months, and died in the eighth month due to refractory seizures.
Conclusion
In hypotonic infants presenting with cataracts and cardiomyopathy, elevated plasma lactate levels and increased urinary excretion of 3-methylglutaconate and 3-methylglutarate may suggest PHRINL syndrome; however, the diagnosis should not be excluded solely on the basis of normal metabolic test results when characteristic clinical features are present.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatric Nutrition and Metabolism, Kocaeli City Hospital, Kocaeli, Türkiye.
- Department of Pediatric Neurology, Kocaeli City Hospital, Kocaeli, Türkiye.
- Genoks Genetic Diseases Diagnostic Center, Ankara, Türkiye.
- Department of Pediatric Neurology, Kocaeli Univesity Faculty of Medicine, Kocaeli, Türkiye.
Zitieren
APA
Gülbahçe, A., Deniz, A., Tekin, İ. M., & Kara, B. (2026). PHRINL Syndrome: A Case of Infantile Cataract and Cardiomyopathy. Molecular Syndromology, 1-7. https://doi.org/10.1159/000551787
Vancouver
Gülbahçe A, Deniz A, Tekin İM, Kara B. PHRINL Syndrome: A Case of Infantile Cataract and Cardiomyopathy. Molecular Syndromology. 2026:1-7. doi:10.1159/000551787
BibTeX
@article{Glbahe2026,
author = {Gülbahçe, Aliye and Deniz, Adnan and Tekin, İsmihan Merve and Kara, Bülent},
title = {PHRINL Syndrome: A Case of Infantile Cataract and Cardiomyopathy},
journal = {Molecular Syndromology},
year = {2026},
pages = {1--7},
doi = {10.1159/000551787}
}
EUVIMED